Galmed Pharmaceuticals Ltd. Announces Restructured Acquisition Terms for Colospan Ltd., Prioritizing CG-100 European Commercialization and Shareholder Value Protection and Consummation of Acquisition
Go back to Galmed Pharmaceuticals Ltd. Announces Restructured Acquisition Terms for Colospan Ltd., Prioritizing CG-100 European Commercialization and Shareholder Value Protection and Consummation of Acquisition| GALMED PHARMACEUTIC (NASDAQ: GLMD) | Delayed: 4.63 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.63 | 52 Week High | $9.70 | |||
| Open | $4.63 | 52 Week Low | $2.78 | |||
| Day High | $4.63 | P/E | N/A | |||
| Day Low | $4.63 | EPS | $0.00 | |||
| Volume | 439,398 | |||||
